Kanabo Group (STU:3WD) Other Operating Expense: €2.59 Mil (TTM As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kanabo Group Other Operating Expense?

Kanabo Group STU:3WD Other Operating Expense is €2.59 Mil as of Jun. 2024.

Kanabo Group's Other Operating Expense for the six months ended in Jun. 2024 was €1.11 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €2.59 Mil.

Kanabo Group's quarterly Other Operating Expense increased from Jun. 2023 (€0.45 Mil) to Dec. 2023 (€1.48 Mil) but then declined from Dec. 2023 (€1.48 Mil) to Jun. 2024 (€1.11 Mil).

Kanabo Group's annual Other Operating Expense increased from Dec. 2021 (€1.80 Mil) to Dec. 2022 (€4.45 Mil) but then declined from Dec. 2022 (€4.45 Mil) to Dec. 2023 (€1.92 Mil).

Kanabo Group Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Kanabo Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kanabo Group Other Operating Expense Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial 0.00 0.29 1.80 4.45 1.92

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 3.67 0.45 1.48 1.11

Kanabo Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €2.59 Mil mean?
Kanabo Group (STU:3WD) has a Other Operating Expense of €2.59 Mil as of Jun. 2024. Other operating expenses that a company records on its income statement. View historical data on Kanabo Group and its competitors.
Is Kanabo Group's Other Operating Expense too high?
Kanabo Group's current Other Operating Expense is €2.59 Mil.
How does Kanabo Group's Other Operating Expense compare to HCA and THC?
Kanabo Group's Other Operating Expense of €2.59 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Kanabo Group and its competitors. Kanabo Group's current Other Operating Expense is €2.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanabo Group stock overvalued right now?
Kanabo Group (STU:3WD) has a current Other Operating Expense of €2.59 Mil. The current Other Operating Expense is €2.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Kanabo Group (STU:3WD), the current Other Operating Expense is €2.59 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kanabo Group Business Description

Address 137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.